Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1999

View Archived Issues

ACE inhibitor quinaprilat stimulates angiogenesis in vivo

Oral mucositis prevention with IB-367 assessed

Chinese herbal medicine demonstrates high efficacy against influenza in mice

Therion Biologics completes financing, accelerates therapeutic vaccine programs

Phase I trial of ThGRF1-44 successfully completed

NeoPharm announces CRADA with NCI for novel anticancer compound

Protein Design Labs enters agreement with Fujisawa

Emisphere and Elan restructure joint venture for development and marketing of oral heparin

In the news: Elan's novel approach to treatment and prevention of AD

Citicoline combination treatment shows synergistic effect in reducing stroke infarct volume

Phase III combination trial begins for ranolazine in stable angina

Pediatric formulation of Viramune now available in the E.U.

Teijin patents novel and clinically useful factor Xa inhibitors

Midostaurin is a promising new agent for preventing vision loss

Cytokine production inhibitors in the pipeline at Sankyo

Metabolite of previously reported compound acts as potent, selective 5-HT4 receptor antagonist

Ono synthesizes compounds that inhibit adhesion molecule expression

Novel FGF discovered at Genentech; antibodies useful for treating, diagnosing tumors

Valentis investigates multiple gene therapy approaches to treatment of arthritis

Selective beta3-receptor agonists in early development at Lilly

Potential new spinal analgesic --MPV-2426-- characterized at Orion

Enspheres are an efficient delivery system for DNA

New nitrone derivative protects against oxidative stress-induced damage

Gene therapy AD21 evaluated in phase I study in cancer patients

LM-1484 should be very effective therapy for bronchial asthma according to preclinical data

MetXia-P450 for GDEPT of cancer

Vaxin develops technology for transdermal vaccine delivery

Abaperidone undergoes extensive efficacy and safety testing at Ferrer

Eisai in-licenses novel antiarthritic from Knoll

FDA advisory committee to consider OTC status for Flexeril

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...